Page last updated: 2024-08-05 11:23:16

endocannabinoid

A class of cannabinoids present in mammalian biological fluids and tissues that activate cannabinoid receptors.

ChEBI ID: 67197

Members (6)

MemberDefinitionRole
anandamideAn N-acylethanolamine 20:4 resulting from the formal condensation of carboxy group of arachidonic acid with the amino group of ethanolamine.anandamide
glyceryl 2-arachidonateAn endocannabinoid and an endogenous agonist of the cannabinoid receptors (CB1 and CB2). It is an ester formed from omega-6-arachidonic acid and glycerol.2-arachidonoylglycerol
N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamineAn N-acylethanolamine 22:6 that is the ethanolamide of (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoic acid.N-(4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoylethanolamine
n-oleoylethanolamineAn N-(long-chain-acyl)ethanolamine that is the ethanolamide of oleic acid. The monounsaturated analogue of the endocannabinoid anandamide.oleoyl ethanolamide
noladin etherA monoalkylglycerol that is glycerol which is substituted by a (5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraen-1-yl group at position 2.2-arachidonyl glyceryl ether
palmidrolAn N-(long-chain-acyl)ethanolamine that is the ethanolamide of palmitic (hexadecanoic) acid.palmitoyl ethanolamide

Research

Studies (3,897)

TimeframeStudies, Drugs in This Class (%)All Drugs %
pre-19909 (0.23)18.7374
1990's353 (9.06)18.2507
2000's1,463 (37.54)29.6817
2010's1,657 (42.52)24.3611
2020's415 (10.65)2.80

Study Types

Publication TypeStudies, Drugs in This Class (%)All Drugs (%)
Trials120 (2.44%)5.53%
Reviews555 (11.29%)6.00%
Case Studies15 (0.31%)4.05%
Observational16 (0.33%)0.25%
Other4,208 (85.63%)84.16%